Biden's COVID program faces uncertainty after funding dropped from bill, and Moderna to trial omicron-specific booster

South Africa News News

Biden's COVID program faces uncertainty after funding dropped from bill, and Moderna to trial omicron-specific booster
South Africa Latest News,South Africa Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

Coronavirus Update: Funding for Biden COVID program dropped from omnibus bill

President Joe Biden’s COVID-19 program faced some uncertainty Thursday, after U.S. lawmakers passed a massive new bill that would fund the federal government for the remainder of the fiscal year, as well as further aid Ukraine, but a last-minute snag resulted in COVID-19 money being dropped.

The news comes as the U.S. is averaging 37,685 new cases a day, according to a New York Times tracker, down 51% from two weeks ago. The average daily number of hospitalizations stands at 33,761, down 44% from two weeks ago.See also: Novak Djokovic, still unvaccinated, can’t travel to U.S. for Miami and Indian Wells tournaments

The study will enroll 375 adults at 20 sites in the U.S. Moderna is also testing a standalone omicron-specific booster candidate in a separate study.• Germany set another record one-day COVID case tally on Thursday, just as the country is set to drop its restrictions, Reuters reported. Germany reported 262,752 new infections, 52,079 more than a week ago, with the seven-day incidence rate rising to 1,389 infections per 100,000 people, from 1,319 a day earlier.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19 news: Drug-resistant mutation linked to a covid treatmentCovid-19 news: Drug-resistant mutation linked to a covid treatmentThe latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Read more »

COVID live updates: COVID testing center opens at Moscone Center in SFCOVID live updates: COVID testing center opens at Moscone Center in SFSF's Travel Association opened the facility to provide visitors, meeting attendees, and residents quick and easy access to affordable testing seven days a week.
Read more »

COVID live updates: WHO says COVID boosters needed, reversing previous callCOVID live updates: WHO says COVID boosters needed, reversing previous callAn expert group convened by the World Health Organization said it 'strongly supports urgent and broad access' to booster doses of COVID-19 vaccine amid the global spread of omicron.
Read more »

Most Side Effects From Pfizer, Moderna Covid Shots Are Mild And Short-Lived, Major Study FindsMost Side Effects From Pfizer, Moderna Covid Shots Are Mild And Short-Lived, Major Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »

'Appalling': Moderna Rebuked Over Latest Covid-19 Vaccine Patent Strategy'Appalling': Moderna Rebuked Over Latest Covid-19 Vaccine Patent Strategy'Billionaire CEO shouldn't get to choose who lives and who dies,' said one advocacy group after Moderna's patent announcement.
Read more »



Render Time: 2025-03-07 03:37:35